Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.

Gencer, Selin; Lacy, Michael; Atzler, Dorothee; van der Vorst, Emiel P C; Döring, Yvonne; Weber, Christian (2020). Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thrombosis and haemostasis, 120(12), pp. 1629-1641. Schattauer 10.1055/s-0040-1718735

[img] Text
GenscerS_ImmunonflammatoryThrombohaemostatic_ThrombHaemost_2020.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (18MB) | Request a copy

The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent history of humankind, afflicting more than 27 million individuals to date. While the majority of COVID-19 patients recuperate, a considerable number of patients develop severe complications. Bilateral pneumonia constitutes the hallmark of severe COVID-19 disease but an involvement of other organ systems, namely the cardiovascular system, kidneys, liver, and central nervous system, occurs in at least half of the fatal COVID-19 cases. Besides respiratory failure requiring ventilation, patients with severe COVID-19 often display manifestations of systemic inflammation and thrombosis as well as diffuse microvascular injury observed postmortem. In this review, we survey the mechanisms that may explain how viral entry and activation of endothelial cells by severe acute respiratory syndrome coronavirus 2 can give rise to a series of events including systemic inflammation, thrombosis, and microvascular dysfunction. This pathophysiological scenario may be particularly harmful in patients with overt cardiovascular disease and may drive the fatal aspects of COVID-19. We further shed light on the role of the renin-angiotensin aldosterone system and its inhibitors in the context of COVID-19 and discuss the potential impact of antiviral and anti-inflammatory treatment options. Acknowledging the comorbidities and potential organ injuries throughout the course of severe COVID-19 is crucial in the clinical management of patients affecting treatment approaches and recovery rate.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Döring, Yvonne

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0340-6245

Publisher:

Schattauer

Language:

English

Submitter:

Rebecca Scheidegger

Date Deposited:

03 Nov 2020 16:44

Last Modified:

05 Dec 2022 15:41

Publisher DOI:

10.1055/s-0040-1718735

PubMed ID:

33124029

BORIS DOI:

10.7892/boris.147781

URI:

https://boris.unibe.ch/id/eprint/147781

Actions (login required)

Edit item Edit item
Provide Feedback